首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1957051

日本儿童医疗保健市场规模、份额、趋势和预测：按类型、治疗方法和地区划分，2026-2034年

Japan Pediatric Healthcare Market Size, Share, Trends and Forecast by Type, Treatment, and Region, 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 150 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本儿童医疗保健市场规模达8.273亿美元。 IMARC集团预测，到2034年，该市场规模将达到12.087亿美元，2026年至2034年的复合年增长率（CAGR）为4.30%。市场成长显着的原因包括：人们对儿童疾病的认识不断提高、儿童治疗技术的进步以及政府为改善儿童医疗保健服务所采取的措施。儿童慢性病和心理健康问题的日益增加也加速了对专业医疗服务的需求。随着医疗基础设施的不断完善和预防措施的日益重视，预计日本儿童医疗保健市场份额将继续增长。

日本儿童医疗保健市场趋势：

老化的影响

随着日本人口老化，人们对儿童发展和长期健康管理的关注度日益提高，儿童医疗服务需求也随之增长。随着老年人口的不断增加，政府和医疗体係正着力于早期诊断和预防，以应对未来的健康挑战。为因应这些趋势，近期推出的法律改革旨在支持家庭，并保障儿童的健康未来。例如，2024年6月，日本国会通过立法，扩大了儿童津贴和育婴假的覆盖范围，以应对出生率下降的问题，并建立更公平的扶持体系。自10月起，享有这些福利的年龄将提高至18岁，育婴假福利也将随之提高，以减轻经济负担对建立家庭的影响。儿童医学如今已成为保障下一代健康综合策略的重要组成部分，不仅关注眼前的医疗需求，也致力于长期的健康促进。这包括对儿童疾病早期疗育，以及倡导健康的生活方式以对抗肥胖和糖尿病。此外，随着人们对发展障碍和儿童心理健康问题的认识不断提高，对专业医疗服务的需求也不断增长。在此背景下，日本老化社会间接催生了对更完善、更具前瞻性的儿童医疗基础设施的需求，从而推动了日本儿童医疗市场的成长。

儿童医学进展

儿童医学的进步在满足儿童独特的健康需求方面发挥着至关重要的作用。针对不同年龄层的特效药物和治疗方法的研发正在改善年轻患者的治疗效果。与成人不同，儿童对药物的生理反应存在差异，因此，针对不同年龄的药物配方对于确保疗效和安全性至关重要。目前正在研发的新药旨在更精准地治疗儿童常见疾病，如气喘、糖尿病和癫痫，并减少副作用。例如，2025年3月，日本新药株式会社在日本推出了用于治疗儿童肺动脉高压（PAH）的口服药物「UpTravi 0.05mg片剂」。这种口服药物满足了儿童治疗领域的关键需求，此前儿科治疗仅限于注射剂。该公司将继续致力于开发针对罕见疾病的创新解决方案，并改善患者照护。此外，针对遗传性疾病和发育障碍的儿童特效治疗方法和疫苗也日益受到关注。非侵入性诊断技术的快速发展，包括用于监测儿童健康的可穿戴设备，也使得更及时、更精准的介入成为可能。儿童医疗保健领域的这些进步不仅改善了治疗效果，也确保了儿童能够获得根据其个人需求量身定制的最佳护理，从而对日本儿童医疗保健市场产生了重大影响。

本报告解答的主要问题

日本儿童医疗保健市场迄今为止的发展如何？预计未来几年将如何发展？
日本儿童医疗保健市场按类型是如何细分的？
日本儿童医疗保健市场按治疗方法是如何分類的？
日本儿童医疗保健市场按地区分類的组成是怎样的？
日本儿童医疗保健市场价值链的不同阶段有哪些？
日本儿童医疗保健市场的主要驱动因素和挑战是什么？
日本儿童医疗保健市场的结构是怎么样的？主要参与者有哪些？
日本儿童医疗保健市场的竞争程度如何？

The Japan pediatric healthcare market size reached USD 827.3 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 1,208.7 Million by 2034 , exhibiting a growth rate (CAGR) of 4.30 % during 2026-2034 . The market is experiencing significant growth due to a growing focus on childhood diseases, advancements in pediatric treatments, and government initiatives to improve child healthcare access. The increasing prevalence of chronic conditions and mental health concerns among children is also escalating the demand for specialized care. With enhanced healthcare infrastructure and a focus on preventive measures, the Japan pediatric healthcare market share is further poised for continued growth.

JAPAN PEDIATRIC HEALTHCARE MARKET TRENDS:

Aging Population Impact

Japan's aging population is driving a growing need for pediatric healthcare services, with increased focus on child development and long-term health management. As the elderly population rises, the government and healthcare systems are emphasizing early diagnosis and prevention to manage future health challenges. In response to these dynamics, recent legislative changes aim to support families and ensure a healthier future for children. For instance, in June 2024, Japan's parliament passed a law to increase child allowances and parental leave in response to the country's declining birthrate, aiming for equitable support. Starting in October, coverage will be extended to age 18, and benefits for childcare leave will increase amidst concerns about financial barriers impacting family growth. Pediatric care is now seen as part of the broader strategy to ensure a healthier next generation, addressing not only immediate healthcare needs but also fostering long-term well-being. This includes early interventions for childhood diseases and the promotion of healthier lifestyles to combat issues like obesity and diabetes. Additionally, a growing awareness of developmental disorders and mental health concerns in children has led to an increased demand for specialized care. As a result, the aging demographic has indirectly shaped the demand for a more robust and future-ready pediatric healthcare infrastructure in Japan, contributing to Japan pediatric healthcare market growth.

Advances in Pediatric Medicine

Advances in pediatric medicine are playing a crucial role in addressing the unique health needs of children. The development of specialized, age-appropriate medications and treatment methods has improved care outcomes for young patients. Unlike adults, children have different physiological responses to medications, making age-specific formulations essential for efficacy and safety. New medications are being developed to treat common pediatric conditions like asthma, diabetes, and epilepsy with higher precision and fewer side effects. For instance, in March 2025, Nippon Shinyaku Co., Ltd. launched Uptravi 0.05 mg tablets in Japan for treating pediatric pulmonary arterial hypertension (PAH). This oral medication addresses a significant need for pediatric treatments, previously limited to injectables. The company continues to focus on developing innovative solutions for rare diseases and enhancing patient care. Moreover, pediatric-specific treatments and vaccines for genetic and developmental disorders are increasingly receiving attention. Rapid progress in non-invasive diagnostic technologies, including wearables for monitoring the health of children, is also making interventions timelier and more precise. Such pediatric advances in medicine not only increase treatment efficacy but also ensure that children get the best care possible, specific to their needs, and have a strong influence on the Japan pediatric healthcare market.

JAPAN PEDIATRIC HEALTHCARE MARKET SEGMENTATION:

Type Insights:

Chronic Illness
Acute Illness

Treatment Insights:

Vaccines
Drugs
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the Japan pediatric healthcare market performed so far and how will it perform in the coming years?
What is the breakup of the Japan pediatric healthcare market on the basis of type?
What is the breakup of the Japan pediatric healthcare market on the basis of treatment?
What is the breakup of the Japan pediatric healthcare market on the basis of region?
What are the various stages in the value chain of the Japan pediatric healthcare market?
What are the key driving factors and challenges in the Japan pediatric healthcare market?
What is the structure of the Japan pediatric healthcare market and who are the key players?
What is the degree of competition in the Japan pediatric healthcare market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pediatric Healthcare Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Pediatric Healthcare Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Pediatric Healthcare Market - Breakup by Type

6.1 Chronic Illness
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Acute Illness
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan Pediatric Healthcare Market - Breakup by Treatment

7.1 Vaccines
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Drugs
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Others
- 7.3.1 Historical and Current Market Trends (2020-2025)
- 7.3.2 Market Forecast (2026-2034)

8 Japan Pediatric Healthcare Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Type
- 8.1.4 Market Breakup by Treatment
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Type
- 8.2.4 Market Breakup by Treatment
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Type
- 8.3.4 Market Breakup by Treatment
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Type
- 8.4.4 Market Breakup by Treatment
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Type
- 8.5.4 Market Breakup by Treatment
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Type
- 8.6.4 Market Breakup by Treatment
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Type
- 8.7.4 Market Breakup by Treatment
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Type
- 8.8.4 Market Breakup by Treatment
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Pediatric Healthcare Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Products Offered
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Products Offered
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Products Offered
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Products Offered
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Products Offered
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Pediatric Healthcare Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis